• +1-646-491-9876
    • +91-20-67278686

    Search

    Migraine Pipeline Review H1 2017

    Migraine Pipeline Review H1 2017

    • Report Code ID: RW0001799288
    • Category Pharmaceuticals
    • No. of Pages 184
    • Publication Month May-17
    • Publisher Name Global Markets Direct
    Migraine - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Migraine - Pipeline Review, H1 2017, provides an overview of the Migraine (Central Nervous System) pipeline landscape.

    Migraine is a disorder characterized by repeated attacks of severe headache. A migraine headache causes throbbing or pulsating pain, usually on only one side of the head. These headaches are often associated with nausea, vomiting, and extreme sensitivity to light and sound. Symptoms include problems speaking, tingling in face, arms, and shoulders, pain behind one of the eyes and pain that gets worse with routine physical activity.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Migraine - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Migraine (Central Nervous System) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Migraine (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Migraine and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 1, 13, 14, 14, 21, 4 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 2 and 3 molecules, respectively.

    Migraine (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Migraine (Central Nervous System) .
    - The pipeline guide reviews pipeline therapeutics for Migraine (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Migraine (Central Nervous System) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Migraine (Central Nervous System) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Migraine (Central Nervous System)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Migraine (Central Nervous System) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Migraine (Central Nervous System) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    Table of Contents 2
    Introduction 4
    Migraine - Overview 5
    Migraine - Therapeutics Development 6
    Migraine - Therapeutics Assessment 17
    Migraine - Companies Involved in Therapeutics Development 27
    Migraine - Drug Profiles 46
    Migraine - Dormant Projects 158
    Migraine - Discontinued Products 162
    Migraine - Product Development Milestones 163
    Appendix 175

    List of Tables

    Number of Products under Development for Migraine, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..2) , H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..2) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..3) , H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..1) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1) , H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Migraine - Pipeline by 4P Therapeutics LLC, H1 2017
    Migraine - Pipeline by Achelios Therapeutics Inc, H1 2017
    Migraine - Pipeline by Acorda Therapeutics Inc, H1 2017
    Migraine - Pipeline by Alder Biopharmaceuticals Inc, H1 2017
    Migraine - Pipeline by Allergan Plc, H1 2017
    Migraine - Pipeline by Amgen Inc, H1 2017
    Migraine - Pipeline by Aralez Pharmaceuticals Inc, H1 2017
    Migraine - Pipeline by Astellas Pharma Inc, H1 2017
    Migraine - Pipeline by Avanir Pharmaceuticals Inc, H1 2017
    Migraine - Pipeline by Biofrontera AG, H1 2017
    Migraine - Pipeline by BioHealthonomics Inc, H1 2017
    Migraine - Pipeline by Charleston Laboratories Inc, H1 2017
    Migraine - Pipeline by Corium International Inc, H1 2017
    Migraine - Pipeline by Eli Lilly and Company, H1 2017
    Migraine - Pipeline by Impel NeuroPharma Inc, H1 2017
    Migraine - Pipeline by InKemia IUCT Group SA, H1 2017
    Migraine - Pipeline by InStar Technologies AS, H1 2017
    Migraine - Pipeline by Ionis Pharmaceuticals Inc, H1 2017
    Migraine - Pipeline by Klaria Pharma Holding AB, H1 2017
    Migraine - Pipeline by Medestea Research & Production SpA, H1 2017
    Migraine - Pipeline by Merck & Co Inc, H1 2017
    Migraine - Pipeline by Monosol Rx LLC, H1 2017
    Migraine - Pipeline by NAL Pharmaceuticals Ltd, H1 2017
    Migraine - Pipeline by Promius Pharma LLC, H1 2017
    Migraine - Pipeline by RedHill Biopharma Ltd, H1 2017
    Migraine - Pipeline by Revance Therapeutics Inc, H1 2017
    Migraine - Pipeline by Shin Nippon Biomedical Laboratories Ltd, H1 2017
    Migraine - Pipeline by Suda Ltd, H1 2017
    Migraine - Pipeline by Teva Pharmaceutical Industries Ltd, H1 2017
    Migraine - Pipeline by TheraJect Inc, H1 2017
    Migraine - Pipeline by Tonix Pharmaceuticals Holding Corp, H1 2017
    Migraine - Pipeline by Trevena Inc, H1 2017
    Migraine - Pipeline by Trigemina Inc, H1 2017
    Migraine - Pipeline by TrioxBio Inc, H1 2017
    Migraine - Pipeline by Vertex Pharmaceuticals Inc, H1 2017
    Migraine - Pipeline by Xenon Pharmaceuticals Inc, H1 2017
    Migraine - Pipeline by Zosano Pharma Corp, H1 2017
    Migraine - Dormant Projects, H1 2017
    Migraine - Dormant Projects, H1 2017 (Contd..1) , H1 2017
    Migraine - Dormant Projects, H1 2017 (Contd..2) , H1 2017
    Migraine - Dormant Projects, H1 2017 (Contd..3) , H1 2017
    Migraine - Discontinued Products, H1 2017

    List of Figures

    Number of Products under Development for Migraine, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Top 10 Routes of Administration, H1 2017
    Number of Products by Stage and Top 10 Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    4P Therapeutics LLC
    Achelios Therapeutics Inc
    Acorda Therapeutics Inc
    Alder Biopharmaceuticals Inc
    Allergan Plc
    Amgen Inc
    Aralez Pharmaceuticals Inc
    Astellas Pharma Inc
    Avanir Pharmaceuticals Inc
    Biofrontera AG
    BioHealthonomics Inc
    Charleston Laboratories Inc
    Corium International Inc
    Eli Lilly and Company
    Impel NeuroPharma Inc
    InKemia IUCT Group SA
    InStar Technologies AS
    Ionis Pharmaceuticals Inc
    Klaria Pharma Holding AB
    Medestea Research & Production SpA
    Merck & Co Inc
    Monosol Rx LLC
    NAL Pharmaceuticals Ltd
    Promius Pharma LLC
    RedHill Biopharma Ltd
    Revance Therapeutics Inc
    Shin Nippon Biomedical Laboratories Ltd
    Suda Ltd
    Teva Pharmaceutical Industries Ltd
    TheraJect Inc
    Tonix Pharmaceuticals Holding Corp
    Trevena Inc
    Trigemina Inc
    TrioxBio Inc
    Vertex Pharmaceuticals Inc
    Xenon Pharmaceuticals Inc
    Zosano Pharma Corp

    Request for Sample

    Report Url http://www.reportsweb.com//migraine-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//migraine-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//migraine-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments